Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Future Microbiology|April 30, 2011
The Ying-Yang of the virus-host interaction: control of the DNA damage responseRenfeng Li, S Diane HaywardTrends in Microbiology|April 24, 2013
Potential of protein kinase inhibitors for treating herpesvirus-associated diseaseRenfeng Li, S Diane HaywardViruses|January 25, 2025
Targeting EBV Episome for Anti-Cancer Therapy: Emerging Strategies and ChallengesFebri Gunawan Sugiokto, Renfeng LiMbio|June 14, 2024
Targeted eradication of EBV-positive cancer cells by CRISPR/dCas9-mediated EBV reactivation in combination with ganciclovirFebri Gunawan Sugiokto, Renfeng LiJournal of Medical Virology|May 16, 2020
Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicinesYunfeng Zheng, Renfeng Li, Shunai LiuFrontiers in Oncology|August 15, 2022
The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinomaJingchang Zhang, Renfeng Li, Shuai HuangCell & Bioscience|July 9, 2021
PIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylationFarjana Saiada, Kun Zhang, Renfeng LiVirology|November 20, 2019
Protein inhibitor of activated STAT1 (PIAS1) inhibits IRF8 activation of Epstein-Barr virus lytic gene expressionKun Zhang, Dong-Wen Lv, Renfeng LiCell Reports|July 11, 2019
Conserved Herpesvirus Protein Kinases Target SAMHD1 to Facilitate Virus ReplicationKun Zhang, Dong-Wen Lv, Renfeng LiPlos Pathogens|January 23, 2018
Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical inductionDong-Wen Lv, Kun Zhang, Renfeng LiPageof 8